As shown in Figure 5, we observed a significant diminished inhibitory effect of CD69+ cells from blood samples of SLE patients on the release of IL-2, IL-6, IL-10, and IL-17 (p < 0.01 in all cases, compared to healthy subjects). The gene discussed is IL17A; the disease is systemic lupus erythematosus.